semaglutide sodium salt | CAS#2924330-56-1 | GLP1 agonist FDA warns about compounded versions
Description
The retrospective matched cohort study involved 16,827 patients evaluated by neuro-ophthalmologists from 2017 to 2023

313 , G342G352 (2017)
Gorina R, Lyck R, Vestweber D, Engelhardt B

Phentermine and Wegovy (semaglutide) work through completely different pathways in the brain and body, yet patients sometimes ask whether stacking them increases weight loss results

These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease
